Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKinsey
QuintilesIMS
Moodys
Queensland Health
Cantor Fitzgerald
Healthtrust
Mallinckrodt
Boehringer Ingelheim

Generated: January 17, 2018

DrugPatentWatch Database Preview

Monarch Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for MONARCH PHARMS, and what generic and branded alternatives to MONARCH PHARMS drugs are available?

MONARCH PHARMS has twenty-two approved drugs.



Summary for Monarch Pharms
US Patents:0
Tradenames:17
Ingredients:14
NDAs:22

Drugs and US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms QUIBRON-T/SR theophylline TABLET, EXTENDED RELEASE;ORAL 087563-001 Jun 21, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms PROLOPRIM trimethoprim TABLET;ORAL 017943-003 Jul 14, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms CORTISPORIN hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate CREAM;TOPICAL 050218-001 Aug 9, 1985 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms SEPTRA GRAPE sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017598-002 Feb 12, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim SUSPENSION;ORAL 017598-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms CORTISPORIN hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 050479-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms NEOSPORIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 060582-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms CORTISPORIN hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 050169-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms NEOSPORIN G.U. IRRIGANT neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 060707-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Monarch Pharms MENEST estrogens, esterified TABLET;ORAL 084950-001 Approved Prior to Jan 1, 1982 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch Pharms QUIBRON-T/SR theophylline TABLET, EXTENDED RELEASE;ORAL 087563-001 Jun 21, 1983 ➤ Subscribe ➤ Subscribe
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim TABLET;ORAL 017376-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Monarch Pharms SEPTRA DS sulfamethoxazole; trimethoprim TABLET;ORAL 017376-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Department of Justice
Fuji
Accenture
Healthtrust
Dow
Fish and Richardson
Julphar
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot